• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   Media   News-Papers  
Title Created Date
Melatonin, "I will explain how there has been a big fraud" 27 April 2014
The melatonin deception 11 April 2014
Di Bella Method, war among white coats! 14 July 2013
"I'll tell you about my lymphoma healed at the fifth attempt" 12 May 2013
Without the Di Bella therapy I am sentenced to death 25 March 2013
"I had three tumors, with the Di Bella Method, they disappeared!" 14 March 2013
Unfair sentence! 07 March 2013
That’s how I cured my wife from a tumor 07 February 2013
That's how chemo damages the heart 30 January 2013
"I am an oncologist and I will explain why the Medicine excludes Di Bella" 18 January 2013
Display # 

Page 1 of 2

  • Start
  • Prev
  • 1
  • 2
  • Next
  • End

Search

Follow us...

Latest

  • Growth hormone receptor promotes breast cancer progression via the BRAF/MEK/ERK signaling pathway
  • GH and IGF1 in cancer therapy resistance
  • Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice
  • About melatonin - 1996
  • Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma
  • The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review
  • DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells
  • Somatostatin and Somatostatin Receptors in Tumour Biology
  • Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma
  • Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells
  • Expression of GHRH-R, a Potentially Targetable Biomarker, in Triple-negative Breast Cancer
  • Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma
  • Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma
  • Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
  • Vitamin C as a Modulator of the Response to Cancer Therapy
  • An update on vitamin D signaling and cancer
  • AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone
  • All-Trans Retinoic Acid Inhibits Human Colorectal Cancer Cells RKO Migration via Downregulating Myosin Light Chain Kinase Expression through MAPK Signaling Pathway

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • How effective is chemo therapy?
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Di Bella Method's improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of Lymphomas
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients